---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-074363"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2022-06-24T23:59:59+00:00"
generated_at: "2026-06-24T23:22:47.205133+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received Nasdaq letter on June 22, 2022 for bid price <$1.00 over 30 consecutive business days ended June 21, 2022.
- Company has 180-day compliance period until December 19, 2022 to regain compliance by closing at $1.00 for 10 consecutive business days.
- If not compliant by Dec 19, may qualify for additional 180 days by meeting all other listing standards and effecting reverse stock split if necessary.
- No immediate impact on listing; common stock continues trading on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001104659-22-074363
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2022-06-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465922074363/0001104659-22-074363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465922074363/tm2219233d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-074363
- JSON: https://secwatch.observer/filing/0001104659-22-074363.json
- Plain text: https://secwatch.observer/filing/0001104659-22-074363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.